The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study
نویسندگان
چکیده
AIMS Type 2 diabetes mellitus is an independent risk factor for the development of heart failure. To better understand the mechanism by which this occurs, we investigated cardiac structure, function, and perfusion in patients with and without diabetes. METHODS AND RESULTS Sixty-five patients with no stenosis >30% on invasive coronary angiography were categorized into diabetes (19) and non-diabetes (46) which was further categorized into prediabetes (30) and controls (16) according to the American Diabetes Association guidelines. Each patient underwent comprehensive cardiovascular magnetic resonance assessment. Left-ventricular (LV) mass, relative wall mass (RWM), Lagrangian circumferential strain, LV torsion, and myocardial perfusion reserve (MPR) were calculated. LV mass was higher in diabetics than non-diabetics (112.8 ± 39.7 vs. 91.5 ± 21.3 g, P = 0.01) and in diabetics than prediabetics (112.8 ± 39.7 vs. 90.3 ± 18.7 g, P = 0.02). LV torsion angle was higher in diabetics than non-diabetics (9.65 ± 1.90 vs. 8.59 ± 1.91°, P = 0.047), and MPR was lower in diabetics than non-diabetics (2.10 ± 0.76 vs. 2.84 ± 1.25 mL/g/min, P = 0.01). There was significant correlation between MPR and early diastolic strain rate (r = -0.310, P = 0.01) and LV torsion (r = -0.306, P = 0.01). In multivariable linear regression analysis, non-diabetics waist-hip ratio, but not body mass index, had a significant association with RWM (Beta = 0.34, P = 0.02). CONCLUSION Patients with diabetes have increased LV mass, LV torsion, and decreased MPR. There is a significant association between decreased MPR and increased LV torsion suggesting a possible mechanistic link between microvascular disease and cardiac dysfunction in diabetes.
منابع مشابه
Subclinical perfusion deficits in patients with Type 2 diabetes detectable with Cardiovascular Magnetic Resonance Imaging
Background An estimated 200 million people worldwide have type 2 diabetes. Type 2 diabetes is recognized as an independent risk factor for adverse cardiac events, such as myocardial infarction. Cardiovascular disease is the leading cause of death amongst diabetic patients. The subclinical pathophysiology of diabetic heart disease predicts global microvascular disease, prior to the onset of over...
متن کاملRelation Between Stress - Induced Myocardial Perfusion Defects on Cardiovascular Magnetic Resonance and Coronary Microvascular Dysfunction in Patients With Cardiac Syndrome
reversible myocardial perfusion defects during stress myocardial scintigraphy (2,3) and, even more, by the evidence of an impaired response to vasodilator stimuli of coronary blood flow and/or resistance, assessed with several different methods (4-10). In particular, a blunted increase in subendocardial flow in response to intravenous administration of adenosine (11) was shown by cardiovascular...
متن کاملGLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus
Pharmacological agents that are based on the gut-derived hormone glucagon-like peptide (GLP)-1 are increasingly used for hyperglycemia management in type 2 diabetes mellitus. Both GLP-1 receptor agonists and inhibitors of the GLP-1–degrading enzyme dipeptidyl peptidase-4 (ie, DPP-4 inhibitors) increase insulin and reduce glucagon secretion, thereby lowering plasma glucose levels. Moreover, GLP-...
متن کاملThe effect of twelve weeks of aerobic interval training on liver complications and cardiovascular risk factors in men with type 2 diabetes
Background & Aims: One of the main complications of type 2 diabetes is cardiovascular complications, which greatly increases mortality and reduces the quality of life of these patients. Complications of type 2 diabetes, which are known as cardiovascular risk factors, include dyslipidemia (1, 3) and high blood pressure, which are common diseases in type 2 diabetes (1, 4). Another complication of...
متن کاملEmpagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
Impaired cardiac microvascular function contributes to diabetic cardiovascular complications although effective therapy remains elusive. Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor recently approved for treatment of type 2 diabetes, promotes glycosuria excretion and offers cardioprotective actions beyond its glucose-lowering effects. This study was designed to evaluate the...
متن کامل